Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.

Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA.

N Engl J Med. 2000 Sep 7;343(10):682-8.

PMID:
10974131
[PubMed - indexed for MEDLINE]
Free Article
2.

Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.

Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, Lucas JD, Rodenberg C, Buch A, Watts NB.

Arch Intern Med. 2005 Jul 25;165(14):1582-9.

PMID:
16043675
[PubMed - indexed for MEDLINE]
3.

Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial.

Davis S, Papalia MA, Norman RJ, O'Neill S, Redelman M, Williamson M, Stuckey BG, Wlodarczyk J, Gard'ner K, Humberstone A.

Ann Intern Med. 2008 Apr 15;148(8):569-77.

PMID:
18413618
[PubMed - indexed for MEDLINE]
4.

Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.

Flöter A, Nathorst-Böös J, Carlström K, von Schoultz B.

Climacteric. 2002 Dec;5(4):357-65.

PMID:
12626215
[PubMed - indexed for MEDLINE]
5.

Sex, hormones, and hysterectomies.

Guzick DS, Hoeger K.

N Engl J Med. 2000 Sep 7;343(10):730-1. No abstract available.

PMID:
10974139
[PubMed - indexed for MEDLINE]
6.

Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.

Davis SR, van der Mooren MJ, van Lunsen RH, Lopes P, Ribot C, Rees M, Moufarege A, Rodenberg C, Buch A, Purdie DW.

Menopause. 2006 May-Jun;13(3):387-96. Erratum in: Menopause. 2006 Sep-Oct;13(5):850. Ribot, Jean [corrected to Ribot, Claude].

PMID:
16735935
[PubMed - indexed for MEDLINE]
7.

Treatment with percutanous testosterone gel in postmenopausal women with decreased libido--effects on sexuality and psychological general well-being.

Nathorst-Böös J, Flöter A, Jarkander-Rolff M, Carlström K, Schoultz Bv.

Maturitas. 2006 Jan 10;53(1):11-8. Epub 2005 Sep 23.

PMID:
16183220
[PubMed - indexed for MEDLINE]
8.

Testosterone for low libido in postmenopausal women not taking estrogen.

Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M, Braunstein GD, Hirschberg AL, Rodenberg C, Pack S, Koch H, Moufarege A, Studd J; APHRODITE Study Team.

N Engl J Med. 2008 Nov 6;359(19):2005-17. doi: 10.1056/NEJMoa0707302.

PMID:
18987368
[PubMed - indexed for MEDLINE]
Free Article
9.

Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women.

Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR.

Menopause. 2003 Sep-Oct;10(5):390-8.

PMID:
14501599
[PubMed - indexed for MEDLINE]
10.

Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial.

Davis SR, Goldstat R, Papalia MA, Shah S, Kulkarni J, Donath S, Bell RJ.

Menopause. 2006 Jan-Feb;13(1):37-45.

PMID:
16607097
[PubMed - indexed for MEDLINE]
11.

Do women with impaired sexual function following oophorectomy benefit from transdermal testosterone at a physiologic dose?

Reynolds PL.

J Fam Pract. 2000 Dec;49(12):1148. No abstract available.

PMID:
11132065
[PubMed - indexed for MEDLINE]
12.

Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.

Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A, Rodenberg CA, Wekselman K, Casson P.

Obstet Gynecol. 2005 May;105(5 Pt 1):944-52.

PMID:
15863529
[PubMed - indexed for MEDLINE]
13.

A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.

Hilditch JR, Lewis J, Ross AH, Peter A, van Maris B, Franssen E, Charles J, Norton P, Dunn EV.

Maturitas. 1996 Jul;24(3):177-84.

PMID:
8844631
[PubMed - indexed for MEDLINE]
15.

Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.

Kingsberg S, Shifren J, Wekselman K, Rodenberg C, Koochaki P, Derogatis L.

J Sex Med. 2007 Jul;4(4 Pt 1):1001-8.

PMID:
17627745
[PubMed - indexed for MEDLINE]
16.

Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women.

Kingsberg S.

J Sex Med. 2007 Mar;4 Suppl 3:227-34. Review.

PMID:
17394595
[PubMed - indexed for MEDLINE]
17.

The brief index of sexual functioning for women (BISF-W): a new scoring algorithm and comparison of normative and surgically menopausal populations.

Mazer NA, Leiblum SR, Rosen RC.

Menopause. 2000 Sep-Oct;7(5):350-63.

PMID:
10993034
[PubMed - indexed for MEDLINE]
18.

Hysterectomy, oophorectomy, and cognitive function in older women.

Kritz-Silverstein D, Barrett-Connor E.

J Am Geriatr Soc. 2002 Jan;50(1):55-61.

PMID:
12028247
[PubMed - indexed for MEDLINE]
19.

The role of androgen in the maintenance of sexual functioning in oophorectomized women.

Sherwin BB, Gelfand MM.

Psychosom Med. 1987 Jul-Aug;49(4):397-409.

PMID:
3615768
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk